Skip to main content
S

SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603008 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,677 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603008

About SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD.

SLEEMON HEALTHY SLEEP TECHNOLOGY CO., LTD. focuses on the research, development, and production of comprehensive sleep solutions. The company’s primary product range includes spring mattresses, latex mattresses, smart sleep systems, and upholstered furniture. By integrating ergonomic design with advanced material science, the firm develops products aimed at enhancing sleep health and spinal support. Its operations encompass the entire value chain, from design and manufacturing to global distribution. Sleemon serves a diverse clientele, including individual consumers and large-scale hospitality providers, offering both standardized and bespoke bedding products. The company distinguishes itself through its commitment to technological innovation in sleep science, utilizing automated manufacturing and smart monitoring features to provide data-driven sleep improvements.

Recent filings

Filing Released Lang Actions
喜临门健康睡眠科技股份公司关于上海证券交易所对公司银行账户资金划转及冻结相关事项的监管工作函的回复公告
Regulatory Filings Classification · 1% confidence The document is a formal public reply by the company to regulatory letters from the Shanghai Stock Exchange regarding bank account fund transfers, freezes, and related internal control issues. It does not itself present financial results (so not ER or IR), management discussion (MDA), or an annual/interim report. It’s not a board change (MANG), a proxy statement (PSI), or a dividend notice (DIV). Rather it is a regulatory disclosure of material events and responses to exchange inquiries, fitting the catch-all “Regulatory Filings” category (RNS).
2026-04-24 Chinese
喜临门健康睡眠科技股份公司2025年年度报告
Annual Report Classification · 1% confidence The document is titled '2025年度报告' (2025 Annual Report) and contains standard sections for an annual report, including 'Management Discussion and Analysis', 'Financial Reports', 'Corporate Governance', and 'Major Financial Indicators'. It is a comprehensive document (203 pages total) detailing the company's performance, financial statements, and business operations for the fiscal year 2025. It is not a short announcement or a summary, but the full report itself. FY 2025
2026-04-24 Chinese
喜临门健康睡眠科技股份公司关于2026年度日常关联交易预计的公告
Regulatory Filings Classification · 1% confidence The document is an official announcement by a Chinese listed company (SSE code 603008) regarding its projected ordinary related‐party transactions for the 2026 fiscal year. It details board approval procedures, transaction categories, counterparties, amounts, pricing policy, and impact on the company. This is a regulatory disclosure of related‐party transactions and does not fit any more specific category such as earnings release, capital update, share issue, or financial report. Therefore, it falls into the fallback “Regulatory Filings” category.
2026-04-24 Chinese
喜临门健康睡眠科技股份公司2025年度会计师事务所履职情况评估报告
Audit Report / Information Classification · 1% confidence The document is a standalone evaluation of the external auditor’s performance, covering qualifications, independence, quality control, execution of the 2025 audit, and related audit‐service matters. It is not an annual report, management change notice, earnings release, or mere publication announcement. It is an audit‐related information report, fitting the definition of “Audit Report / Information (AR).”
2026-04-24 Chinese
喜临门健康睡眠科技股份公司关于2025年度“提质增效重回报”行动方案的评估报告暨2026年度“提质增效重回报”行动方案
Management Reports Classification · 1% confidence The document is a long, detailed announcement by the board of 喜临门健康睡眠科技股份公司 evaluating its 2025 “提质增效重回报” action plan and laying out the 2026 action plan. It covers business strategy, operational performance, R&D, investor returns, corporate governance, and internal controls. It is not a brief press release or regulatory notice, but a substantive management discussion of past performance and future outlook. This aligns with the Management Reports (MDA) category, which captures management’s detailed explanation of business trends and plans.
2026-04-24 Chinese
喜临门健康睡眠科技股份公司关于实施其他风险警示暨停牌的公告
Regulatory Filings Classification · 1% confidence The document is an exchange-mandated announcement regarding a risk warning (‘ST’) implementation and a one-day trading suspension under Shanghai Stock Exchange listing rules. It is not a financial report, earnings release, dividend notice, or management change, but rather a general regulatory disclosure concerning the company’s trading status and related governance matters. Therefore, it falls under the general regulatory filings category.
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.